Bill Text: IA HSB616 | 2023-2024 | 90th General Assembly | Introduced


Bill Title: A bill for an act relating to the ordering and administering of epinephrine auto-injectors for persons ages eighteen years and older by a pharmacist pursuant to statewide protocols.

Spectrum: Committee Bill

Status: (Introduced) 2024-02-05 - Subcommittee recommends amendment and passage. Vote Total: 3-0. [HSB616 Detail]

Download: Iowa-2023-HSB616-Introduced.html
House Study Bill 616 - Introduced HOUSE FILE _____ BY (PROPOSED COMMITTEE ON HEALTH AND HUMAN SERVICES BILL BY CHAIRPERSON MEYER) A BILL FOR An Act relating to the ordering and administering of 1 epinephrine auto-injectors for persons ages eighteen years 2 and older by a pharmacist pursuant to statewide protocols. 3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: 4 TLSB 6013YC (2) 90 pf/ko
H.F. _____ Section 1. Section 155A.46, subsection 1, paragraph a, Code 1 2024, is amended by adding the following new subparagraph: 2 NEW SUBPARAGRAPH . (8) Epinephrine auto-injectors. 3 EXPLANATION 4 The inclusion of this explanation does not constitute agreement with 5 the explanation’s substance by the members of the general assembly. 6 This bill relates to the ordering and administering 7 of epinephrine auto-injectors by a pharmacist without a 8 prescription, subject to statewide protocols and other 9 requirements. 10 The bill provides that in accordance with statewide 11 protocols developed by the board of pharmacy in consultation 12 with the department of health and human services, a pharmacist 13 may order and administer an epinephrine auto-injector to 14 a person who is at least 18 years of age. Current Code 15 section 155A.46(2) requires that a pharmacist ordering 16 and administering prescription drugs, products, tests, and 17 treatments under the statewide protocols shall do all of the 18 following: maintain a record of all prescription drugs, 19 products, tests, and treatments administered pursuant to 20 the bill; notify the patient’s primary health care provider 21 of any prescription drugs, products, tests, or treatments 22 administered to the patient, or enter such information in a 23 patient record system also used by the primary health care 24 provider, as permitted by the primary health care provider; 25 if the patient does not have a primary health care provider, 26 provide the patient with a written record of the prescription 27 drugs, products, tests, or treatment provided to the patient 28 and advise the patient to consult a physician; and complete 29 continuing pharmacy education related to statewide protocols. 30 -1- LSB 6013YC (2) 90 pf/ko 1/ 1
feedback